Envoy Medical, Inc.
COCH· Nasdaq
COCHEnvoy Medical, Inc.
Filed Nov 17, 2023 · 10-Q · 48 days after period end · 0001213900-23-088310
| Metric | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|
| Revenue | $80.00K | $57.00K | — |
| Net Income | $1.56M | -$1.34M | $5.57M |
| EPS Diluted | $0.13 | -$0.13 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 17, 2023 · 48 d after period end
